Envoy Medical (COCHW) Invested Capital (2020 - 2026)

Envoy Medical has disclosed Invested Capital across 7 years of filings, most recently posting $10.2 million for Q1 2026.

• Invested Capital for Q1 2026 came in at $10.2 million, up 141.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.2 million (up 141.95% YoY), and the FY2025 annual result was -$12.2 million, up 35.47% from the prior year.
• Invested Capital came in at $10.2 million for Q1 2026 at Envoy Medical, up from -$12.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $10.2 million in Q1 2026 to a low of -$47.5 million in Q1 2023.
• The 5-year median for Invested Capital is -$18.8 million (2024), against an average of -$19.0 million.
• Across the five-year window, Invested Capital slumped 1186.14% in 2024 and surged 141.95% in 2026, its largest moves.
• Envoy Medical's Invested Capital stood at -$35.9 million in 2022, then soared by 95.91% to -$1.5 million in 2023, then plunged by 1186.14% to -$18.8 million in 2024, then surged by 35.47% to -$12.2 million in 2025, then surged by 183.57% to $10.2 million in 2026.
• The last three Invested Capital figures came in at $10.2 million (Q1 2026), -$12.2 million (Q4 2025), and -$7.7 million (Q3 2025), per Business Quant data.